Search research articles
Contact Us
Filters
Showing results (51-60 of 52) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 52 results.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial
Ming Jie Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
The Lancet. HIV
|
May 27, 2026
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial
Ming J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 52) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 52 results.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial
Ming Jie Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
The Lancet. HIV
|
May 27, 2026
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial
Ming J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
Page
of 6